OQROStart free trial
Politician trade (Senate)

Bristol Myers Squibb (BMY): Sen. Tommy Tuberville disclosed a purchase $15K–$50K

Sen. Tommy Tuberville disclosed a purchase of Bristol Myers Squibb in the $15K–$50K range.

$15,001–$50,000
Reported range · official band, not an exact amount
28 days
Disclosure lag
Traded
Jul 16, 2021
Disclosed
Aug 13, 2021

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Jul 16, 2021 · this disclosureCongressDisclosed purchase of BMY — reported range $15,001 - $50,000

What came next

  1. Sep 22, 2021CongressDisclosed purchase of BMY — reported range $1,001 - $15,000
  2. Sep 23, 2021CongressDisclosed purchase of BMY — reported range $1,001 - $15,000
View the official recordSenate eFD periodic transaction report

How to read Senate eFD periodic transaction report

The STOCK Act is a 2012 US law that requires members of Congress, and some senior staff, to publicly report their stock trades, and those of their spouse and dependent children, within 45 days.

Full guide: What is the STOCK Act?

What else is on file for Bristol Myers Squibb

For Bristol Myers Squibb, OQRO holds 3 insider filings (SEC Form 4 or Form 144) and 26 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its BMY page.

Other recent filings by Sen. Tommy Tuberville

The full history of Sen. Tommy Tuberville is on the profile page.

How this filing works

Explore the data

Other disclosures at Bristol Myers Squibb

Everything OQRO holds on this company is on its BMY page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

Start free trialAlready have an account? Log in

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data